Baduanjin · Randomised trial

Baduanjin and Sleep: What a 12-Week Trial Reported

Read what a small Baduanjin trial in older adults reported about sleep at four and 12 weeks, and what its abstract leaves unclear about size and safety.

The short answer

The abstract reports better sleep questionnaire results than no intervention from week four through week 12. It does not provide enough data to predict a personal improvement, a deadline for results or what happened after practice stopped.

Study and source overview

Does a reported difference at four weeks mean that I will sleep better after four weeks?

Participants
Adults aged 60 or older in an urban community in northern Taiwan, independent in self-care and without regular exercise in the previous six months. People with impaired mobility, unstable health or a specified depression-screening score were excluded.
Participant counts
The abstract reports 202 people screened, 87 eligible and 55 completing 12 weeks: 27 in the exercise group and 28 in the control group. The 55 are not all initially eligible people.
Comparison and measurement
Twelve weeks of Baduanjin training versus no intervention. The Pittsburgh Sleep Quality Index (PSQI) was administered at baseline and weeks four, eight and 12.
Publication and access
Published online in 2011 and in the 2012 journal issue. We checked the complete public abstract, not the full text.

What kind of sleep change was measured?

PSQI is a questionnaire about sleep. The study did not use brain-wave sleep testing to establish that each person's insomnia was cured. The abstract does not give a between-group difference that can be translated into an extra hour of sleep.

Time or measureWhat the abstract reportsWhat remains unknown
Weeks four to 12The exercise group reported better sleep quality than the no-intervention group from week four, maintained through week 12.This does not guarantee a four-week response for everyone. The abstract does not report persistence after the course.
Week-12 questionnaireReported improvements included overall sleep quality, sleep latency, duration, efficiency and daytime functioning.Between-group values and confidence intervals for each measure are not supplied, so the size and perceptibility of changes cannot be established here.

Improvement within a group and the amount of improvement beyond a control group are different questions. The abstract supports the direction of the comparison but not an estimate for an individual reader.

What do 55 completers tell us?

Screening 202 people, identifying 87 eligible people and recording 55 completers are different stages. The abstract does not fully reconstruct randomisation, refusal, dropout reasons and missing-data handling. The other people cannot simply be counted as unsuccessful treatment or safe withdrawals.

This was a particular regional sample of independently living older adults, not necessarily people with diagnosed chronic insomnia. Younger adults, people with limited mobility and people with unstable health are not automatically comparable.

The control group did not receive an equivalent exercise, classroom or contact programme. The trial therefore does not establish superiority over walking, tai chi or another guided activity. The abstract also lacks enough detail on frequency, session length, supervision and adverse events to specify a home-practice programme.

How can I use this finding?

The result concerns what this group of older adults reported under this study arrangement. It cannot assess a reader's sleep difficulties or determine whether they should wait four or 12 weeks before seeking help.

For other populations and follow-up questions, read qigong and sleep research. This trial was included in the 2017 review; they are not two independent replications.

Original source and review coverage

Chen MC, Liu HE, Huang HY, Chiou AF. The effect of a simple traditional exercise programme (Baduanjin exercise) on sleep quality of older adults: a randomized controlled trial. International Journal of Nursing Studies. 2012;49(3):265-273.

DOI:10.1016/j.ijnurstu.2011.09.009

Open the original source ↗

Review coverage: Complete public abstract, PubMed ID 21963235, retrieved through the official Europe PMC API. We did not obtain full-text randomisation details, group-specific dropout reasons, between-group tables or complete safety information.

By First Chi; source checked .The paper was published in 2012; the website update date does not replace that date.

First Chi

Learn the steps. Follow the cues. Keep a record.